Free Trial

ALX Oncology (ALXO) SEC Filings & 10K Form

ALX Oncology logo
$0.66 -0.06 (-8.27%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$0.67 +0.01 (+1.66%)
As of 03/28/2025 07:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent ALX Oncology SEC Filings

DateFilerForm TypeView
03/18/2025
3:45 PM
ALX Oncology (Issuer)
Pinto Shelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
3:41 PM
ALX Oncology (Issuer)
Lettmann Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
4:26 PM
ALX Oncology (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/21/2025
3:20 PM
ALX Oncology (Issuer)
Lettmann Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
3:23 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:27 PM
ALX Oncology (Issuer)
Takimoto Chris H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:29 PM
ALX Oncology (Issuer)
GOODMAN COREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:30 PM
ALX Oncology (Issuer)
Garland J. Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:32 PM
ALX Oncology (Issuer)
Hemrajani Rekha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:14 PM
ALX Oncology (Issuer)
Pinto Shelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:17 PM
ALX Oncology (Issuer)
Shantharam Harish (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/23/2025
5:19 PM
ALX Oncology (Issuer)
Shantharam Harish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:22 PM
ALX Oncology (Issuer)
Klencke Barbara (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/23/2025
5:24 PM
ALX Oncology (Issuer)
Klencke Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:25 PM
ALX Oncology (Issuer)
Takimoto Chris H (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/23/2025
5:07 PM
ALX Oncology (Issuer)
Lettmann Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:09 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:11 PM
ALX Oncology (Issuer)
Sandler Alan B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
7:01 AM
ALX Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2025
3:39 PM
ALX Oncology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/17/2025
3:41 PM
ALX Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:10 PM
ALX Oncology (Issuer)
Pinto Shelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:43 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:46 PM
ALX Oncology (Issuer)
Pinto Shelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:12 PM
ALX Oncology (Subject)
Form SC TO-I/A
12/27/2024
3:05 PM
ALX Oncology (Subject)
HBM Healthcare Investments Ltd. (0001232258) (Filed by)
Form SCHEDULE 13G
12/06/2024
10:33 AM
ALX Oncology (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
12/02/2024
3:06 PM
ALX Oncology (Subject)
Form SC TO-I
11/14/2024
6:22 PM
ALX Oncology (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G/A
11/14/2024
5:58 PM
ALX Oncology (Subject)
Vivo Capital Fund IX, L.P. (Filed by)
Form SC 13G/A
11/14/2024
2:02 PM
ALX Oncology (Subject)
Cormorant Asset Management, LP (Filed by)
Form SC 13G/A
11/14/2024
7:03 AM
ALX Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
3:14 PM
ALX Oncology (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G/A
10/04/2024
8:00 AM
ALX Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2024
3:00 PM
ALX Oncology (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
Form SC 13G
08/16/2024
4:05 PM
ALX Oncology (Issuer)
Lettmann Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:06 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:08 PM
ALX Oncology (Issuer)
GARCIA PETER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:09 PM
ALX Oncology (Issuer)
Randolph Sophia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:10 PM
ALX Oncology (Issuer)
Pinto Shelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:17 PM
ALX Oncology (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G
New “Trump” currency proposed in DC (Ad)

According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.

When you see what could happen – I think you’ll be excited.
08/07/2024
4:23 PM
ALX Oncology (Issuer)
Sandler Alan B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:22 PM
ALX Oncology (Issuer)
Sandler Alan B. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/06/2024
3:45 PM
ALX Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2024
3:23 PM
ALX Oncology (Subject)
Pons Jaume (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2024
3:09 PM
ALX Oncology (Issuer)
Pinto Shelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:39 PM
ALX Oncology (Issuer)
GARCIA PETER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
8:00 AM
ALX Oncology (Issuer)
GARCIA PETER S (Reporting)
Form 4/A
06/17/2024
6:29 AM
ALX Oncology (Issuer)
GARCIA PETER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:46 PM
ALX Oncology (Issuer)
Garland J. Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:49 PM
ALX Oncology (Issuer)
Hemrajani Rekha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:42 PM
ALX Oncology (Issuer)
GOODMAN COREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
3:14 PM
ALX Oncology (Subject)
Pons Jaume (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2024
3:10 PM
ALX Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
4:31 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
3:49 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
3:34 PM
ALX Oncology (Subject)
Pons Jaume (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/05/2024
4:37 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
3:37 PM
ALX Oncology (Subject)
Pons Jaume (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:ALXO) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners